For example, targeting TRAF3IP2 inhibited IL1b, IL6, IL8, FGF2, EGF, PDGFRB, PGF, VEGFA, VEGFR2, ANGPT2, and ITGAV expression in GBM cells (Figure 4). This evidence concerns the gene CXCL8 and glioblastoma.